Back HIV Policy & Advocacy

HIV Policy & Advocacy

AIDS 2014: Harm Reduction Funding Is Meeting Only 7% of Global Need

International donors are investing only 7% of what is needed to provide adequate harm reduction coverage for people who inject drugs, according to findings from a report presented this week at the 20th International AIDS Conference in Melbourne. A global commitment to re-balance spending on drug control and harm reduction is essential in order to achieve control of HIV and viral hepatitis among drug injectors, several speakers told the conference.

alt

Read more:

AIDS 2014 Mobilization: Activists Demand More HIV Funding, End Stigma [VIDEO]

Thousands of delegates, advocates, and people living with HIV came together July 22 for the AIDS 2014 Mobilization March and candlelight vigil, held in conjunction with the 20th International AIDS Conference taking place this week in Melbourne. Key themes included the need for more funding to expand access to HIV prevention and treatment, and ending discrimination and criminalization of people with HIV and at-risk groups including gay men, sex workers, and people who use drugs.

alt

Read more:

AIDS 2014: Law and Policy Must Be Part of the Solution for AIDS [VIDEO]

Reforming laws that criminalize and discriminate against people with HIV and key affected populations is a necessary part of the response to the epidemic, according to renowned Australian jurist the Hon. Michael Kirby, speaking at the 20th International AIDS Conference (AIDS 2014) taking place this week in Melbourne, Australia.

alt

Read more:

AIDS 2014: Positively Fabulous Aims to Change HIV+ Women's Lives [VIDEO]

The Positively Fabulous campaign -- participants in the Global Village at the 20th International AIDS Conference taking place this week in Melbourne, Australia --  uses art to empower women living with HIV and helps them set the agenda for responding to the epidemic.

alt

Read more:

TAG Releases 2014 HIV, Hepatitis C, and Tuberculosis Pipeline Report

The Treatment Action Group (TAG) and HIV i-Base this week released the latest edition of their annual Pipeline Report, covering new therapies and related technologies for HIV, hepatitis C, and tuberculosis (TB), in conjunction with the 20th International AIDS Conference taking place this week in Melbourne, Australia.

alt

Read more: